25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Aoxing Pharmaceutical Company Inc
Buy, Hold or Sell?

Let's analyze Aoxing Pharmaceutical Company Inc together

I guess you are interested in Aoxing Pharmaceutical Company Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aoxing Pharmaceutical Company Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aoxing Pharmaceutical Company Inc

I send you an email if I find something interesting about Aoxing Pharmaceutical Company Inc.

1. Quick Overview

1.1. Quick analysis of Aoxing Pharmaceutical Company Inc (30 sec.)










1.2. What can you expect buying and holding a share of Aoxing Pharmaceutical Company Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.05
Expected worth in 1 year
$0.05
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0.0134 - $
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aoxing Pharmaceutical Company Inc (5 min.)




Live pricePrice per Share (EOD)
$0.01
Intrinsic Value Per Share
$0.00 - $0.04
Total Value Per Share
$0.05 - $0.10

2.2. Growth of Aoxing Pharmaceutical Company Inc (5 min.)




Is Aoxing Pharmaceutical Company Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$18m???

How much money is Aoxing Pharmaceutical Company Inc making?

Current yearPrevious yearGrowGrow %
Making money-$14.8k???
Net Profit Margin0.0%?--

How much money comes from the company's main activities?

2.3. Financial Health of Aoxing Pharmaceutical Company Inc (5 min.)




2.4. Comparing to competitors in the Shell Companies industry (5 min.)




  Industry Rankings (Shell Companies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aoxing Pharmaceutical Company Inc?

Welcome investor! Aoxing Pharmaceutical Company Inc's management wants to use your money to grow the business. In return you get a share of Aoxing Pharmaceutical Company Inc.

First you should know what it really means to hold a share of Aoxing Pharmaceutical Company Inc. And how you can make/lose money.

Speculation

The Price per Share of Aoxing Pharmaceutical Company Inc is $0.0148. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aoxing Pharmaceutical Company Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aoxing Pharmaceutical Company Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.05. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aoxing Pharmaceutical Company Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.3%0.00-0.3%0.00-0.3%0.0149.8%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%0.02145.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.000.0%0.02145.8%
Usd Price Per Share0.00-0.00-0.00-0.80-
Price to Earnings Ratio-101.27--101.27--101.27-38.33-
Price-to-Total Gains Ratio-139,603.46--139,603.46--139,603.46--46,511.11-
Price to Book Ratio0.08-0.08-0.08-23.90-
Price-to-Total Gains Ratio-139,603.46--139,603.46--139,603.46--46,511.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0148
Number of shares67567
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (67567 shares)0.000.00
Gains per Year (67567 shares)-0.01-0.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-0-100-0-10
20-0-100-0-10
30-0-100-0-10
40-0-100-0-10
50-0-100-0-10
60-0-100-0-10
70-0-100-0-10
80-0-100-0-10
90-0-100-0-10
100-0-100-0-10

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.01.00.00.0%0.01.00.00.0%2.01.00.066.7%3.010.02.020.0%
Book Value Change Per Share0.01.00.00.0%0.01.00.00.0%0.01.00.00.0%2.01.00.066.7%7.08.00.046.7%
Dividend per Share0.00.01.00.0%0.00.01.00.0%0.00.01.00.0%0.00.03.00.0%0.00.015.00.0%
Total Gains per Share0.01.00.00.0%0.01.00.00.0%0.01.00.00.0%2.01.00.066.7%7.08.00.046.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aoxing Pharmaceutical Company Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%--0.0000%0.022-100%
Book Value Per Share--0.0530.0530%--0.0530%0.045+17%
Current Ratio----0%---0%0.407-100%
Debt To Asset Ratio--0.6790.6790%--0.6790%0.722-6%
Debt To Equity Ratio--1.9941.9940%--1.9940%2.604-23%
Dividend Per Share----0%---0%-0%
Eps--0.0000.0000%--0.0000%0.007-101%
Free Cash Flow Per Share--0.0000.0000%--0.0000%0.000+681%
Free Cash Flow To Equity Per Share----0%---0%0.005-100%
Gross Profit Margin--1.0001.0000%--1.0000%-1.330+233%
Intrinsic Value_10Y_max--0.044--------
Intrinsic Value_10Y_min--0.000--------
Intrinsic Value_1Y_max--0.001--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.005--------
Intrinsic Value_3Y_min--0.000--------
Intrinsic Value_5Y_max--0.013--------
Intrinsic Value_5Y_min--0.000--------
Market Cap5049893.082+70%1501320.4581501320.4580%--1501320.4580%273467633.753-99%
Net Profit Margin----0%---0%0.093-100%
Operating Margin----0%---0%0.174-100%
Operating Ratio----0%---0%0.489-100%
Pb Ratio0.279+70%0.0830.0830%--0.0830%23.897-100%
Pe Ratio-340.634-236%-101.270-101.2700%---101.2700%38.334-364%
Price Per Share0.015+70%0.0040.0040%--0.0040%0.801-99%
Price To Free Cash Flow Ratio-340.634-236%-101.270-101.2700%---101.2700%474.144-121%
Price To Total Gains Ratio-469575.264-236%-139603.457-139603.4570%---139603.4570%-46511.115-67%
Quick Ratio----0%---0%0.250-100%
Return On Assets--0.0000.0000%--0.0000%0.047-101%
Return On Equity---0.001-0.0010%---0.0010%0.199-100%
Total Gains Per Share--0.0000.0000%--0.0000%0.022-100%
Usd Book Value--18075972.00018075972.0000%--18075972.0000%15404955.333+17%
Usd Book Value Change Per Share--0.0000.0000%--0.0000%0.022-100%
Usd Book Value Per Share--0.0530.0530%--0.0530%0.045+17%
Usd Dividend Per Share----0%---0%-0%
Usd Eps--0.0000.0000%--0.0000%0.007-101%
Usd Free Cash Flow---14825.000-14825.0000%---14825.0000%-115745.333+681%
Usd Free Cash Flow Per Share--0.0000.0000%--0.0000%0.000+681%
Usd Free Cash Flow To Equity Per Share----0%---0%0.005-100%
Usd Market Cap5049893.082+70%1501320.4581501320.4580%--1501320.4580%273467633.753-99%
Usd Price Per Share0.015+70%0.0040.0040%--0.0040%0.801-99%
Usd Profit---14825.000-14825.0000%---14825.0000%2513704.000-101%
Usd Revenue----0%---0%19270241.333-100%
Usd Total Gains Per Share--0.0000.0000%--0.0000%0.022-100%
 EOD+5 -3MRQTTM+0 -0YOY+0 -05Y+0 -010Y+14 -20

3.3 Fundamental Score

Let's check the fundamental score of Aoxing Pharmaceutical Company Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-340.634
Price to Book Ratio (EOD)Between0-10.279
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.679
Debt to Equity Ratio (MRQ)Less than11.994
Return on Equity (MRQ)Greater than0.15-0.001
Return on Assets (MRQ)Greater than0.050.000
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Aoxing Pharmaceutical Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5073.707
Ma 20Greater thanMa 500.008
Ma 50Greater thanMa 1000.007
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.011
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Aoxing Pharmaceutical Company Inc

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.

Fundamental data was last updated by Penke on 2024-09-19 18:39:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Aoxing Pharmaceutical Company Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aoxing Pharmaceutical Company Inc to the Shell Companies industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y9.3%-9.3%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--48.1%+48.1%
TTM--6.8%+6.8%
5Y--9.2%+9.2%
10Y9.3%-18.0%+27.3%
4.3.1.2. Return on Assets

Shows how efficient Aoxing Pharmaceutical Company Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aoxing Pharmaceutical Company Inc to the Shell Companies industry mean.
  • 0.0% Return on Assets means that Aoxing Pharmaceutical Company Inc generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 0.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%0.0%
TTM0.0%5Y0.0%0.0%
5Y0.0%10Y4.7%-4.7%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%-0.9%+0.9%
TTM0.0%-0.7%+0.7%
5Y0.0%-1.4%+1.4%
10Y4.7%-1.4%+6.1%
4.3.1.3. Return on Equity

Shows how efficient Aoxing Pharmaceutical Company Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aoxing Pharmaceutical Company Inc to the Shell Companies industry mean.
  • -0.1% Return on Equity means Aoxing Pharmaceutical Company Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is -0.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM-0.1%0.0%
TTM-0.1%5Y-0.1%0.0%
5Y-0.1%10Y19.9%-19.9%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%-1.0%+0.9%
TTM-0.1%-0.3%+0.2%
5Y-0.1%-1.3%+1.2%
10Y19.9%-1.3%+21.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aoxing Pharmaceutical Company Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Aoxing Pharmaceutical Company Inc is operating .

  • Measures how much profit Aoxing Pharmaceutical Company Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aoxing Pharmaceutical Company Inc to the Shell Companies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y17.4%-17.4%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--88.7%+88.7%
TTM--27.9%+27.9%
5Y--26.4%+26.4%
10Y17.4%-36.1%+53.5%
4.3.2.2. Operating Ratio

Measures how efficient Aoxing Pharmaceutical Company Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Shell Companies industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y0.489-0.489
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.361-1.361
TTM-0.866-0.866
5Y-0.478-0.478
10Y0.4890.600-0.111
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aoxing Pharmaceutical Company Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aoxing Pharmaceutical Company Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Shell Companies industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y0.407-0.407
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.054-0.054
TTM-0.101-0.101
5Y-1.674-1.674
10Y0.4071.665-1.258
4.4.3.2. Quick Ratio

Measures if Aoxing Pharmaceutical Company Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aoxing Pharmaceutical Company Inc to the Shell Companies industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y0.250-0.250
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.218-0.218
TTM-0.655-0.655
5Y-3.543-3.543
10Y0.2503.533-3.283
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aoxing Pharmaceutical Company Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Aoxing Pharmaceutical Company Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aoxing Pharmaceutical Company Inc to Shell Companies industry mean.
  • A Debt to Asset Ratio of 0.68 means that Aoxing Pharmaceutical Company Inc assets are financed with 67.9% credit (debt) and the remaining percentage (100% - 67.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 0.679. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.679. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.679TTM0.6790.000
TTM0.6795Y0.6790.000
5Y0.67910Y0.722-0.044
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6790.441+0.238
TTM0.6790.320+0.359
5Y0.6790.351+0.328
10Y0.7220.353+0.369
4.5.4.2. Debt to Equity Ratio

Measures if Aoxing Pharmaceutical Company Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aoxing Pharmaceutical Company Inc to the Shell Companies industry mean.
  • A Debt to Equity ratio of 199.4% means that company has $1.99 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The MRQ is 1.994. The company is just able to pay all its debts with equity.
  • The TTM is 1.994. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.994TTM1.9940.000
TTM1.9945Y1.9940.000
5Y1.99410Y2.604-0.610
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9940.385+1.609
TTM1.9940.277+1.717
5Y1.9940.991+1.003
10Y2.6040.964+1.640
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aoxing Pharmaceutical Company Inc generates.

  • Above 15 is considered overpriced but always compare Aoxing Pharmaceutical Company Inc to the Shell Companies industry mean.
  • A PE ratio of -101.27 means the investor is paying $-101.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The EOD is -340.634. Based on the earnings, the company is expensive. -2
  • The MRQ is -101.270. Based on the earnings, the company is expensive. -2
  • The TTM is -101.270. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-340.634MRQ-101.270-239.364
MRQ-101.270TTM-101.2700.000
TTM-101.2705Y-101.2700.000
5Y-101.27010Y38.334-139.603
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-340.634-11.037-329.597
MRQ-101.270-12.618-88.652
TTM-101.270-6.334-94.936
5Y-101.270-10.159-91.111
10Y38.334-10.159+48.493
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The EOD is -340.634. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -101.270. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -101.270. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-340.634MRQ-101.270-239.364
MRQ-101.270TTM-101.2700.000
TTM-101.2705Y-101.2700.000
5Y-101.27010Y474.144-575.413
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-340.634-55.976-284.658
MRQ-101.270-56.806-44.464
TTM-101.270-76.739-24.531
5Y-101.270-173.223+71.953
10Y474.144-162.595+636.739
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Aoxing Pharmaceutical Company Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Shell Companies industry mean).
  • A PB ratio of 0.08 means the investor is paying $0.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aoxing Pharmaceutical Company Inc:

  • The EOD is 0.279. Based on the equity, the company is cheap. +2
  • The MRQ is 0.083. Based on the equity, the company is cheap. +2
  • The TTM is 0.083. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.279MRQ0.083+0.196
MRQ0.083TTM0.0830.000
TTM0.0835Y0.0830.000
5Y0.08310Y23.897-23.814
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD0.2792.656-2.377
MRQ0.0832.726-2.643
TTM0.0832.547-2.464
5Y0.0831.617-1.534
10Y23.8971.603+22.294
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
 As reported
Total Liabilities 0
Total Stockholder Equity+ 0
Total Assets = 0

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Common Stock Shares Outstanding 341,209



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302003-06-302002-06-302001-06-30
> Total Assets 
7,954
7,777
6,577
5,762
17,979
30,711
56,125
56,744
58,327
58,489
45,090
39,733
38,075
53,041
56,232
0
056,23253,04138,07539,73345,09058,48958,32756,74456,12530,71117,9795,7626,5777,7777,954
   > Total Current Assets 
0
0
0
262
157
1,961
5,254
6,944
8,920
7,378
9,522
11,892
10,921
21,096
26,867
0
026,86721,09610,92111,8929,5227,3788,9206,9445,2541,961157262000
       Cash And Cash Equivalents 
16
36
25
143
1
1,511
1,566
1,272
3,986
2,771
3,683
4,008
2,330
5,372
6,912
0
06,9125,3722,3304,0083,6832,7713,9861,2721,5661,5111143253616
       Short-term Investments 
0
35
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000350
       Net Receivables 
0
0
0
89
0
113
2,536
1,064
2,473
2,008
2,804
2,843
3,891
5,854
11,200
0
011,2005,8543,8912,8432,8042,0082,4731,0642,536113089000
       Inventory 
11
19
20
25
0
220
849
713
1,565
1,469
1,805
2,622
2,195
3,240
2,842
0
02,8423,2402,1952,6221,8051,4691,565713849220025201911
   > Long-term Assets 
0
0
0
5,500
17,822
28,750
50,871
49,800
49,407
51,110
35,568
27,841
27,154
31,945
29,365
0
029,36531,94527,15427,84135,56851,11049,40749,80050,87128,75017,8225,500000
       Property Plant Equipment 
7,870
6,439
6,465
5,500
17,822
19,219
30,331
29,324
25,570
26,669
26,960
26,942
26,419
28,652
25,604
0
025,60428,65226,41926,94226,96026,66925,57029,32430,33119,21917,8225,5006,4656,4397,870
       Goodwill 
0
0
0
0
0
0
18,905
18,927
19,012
19,916
6,909
0
0
0
0
0
000006,90919,91619,01218,92718,905000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
292
189
96
4
0
049618929200000000000
       Intangible Assets 
0
0
0
0
0
0
1,635
1,549
1,431
1,389
1,299
607
546
485
1,878
0
01,8784855466071,2991,3891,4311,5491,635000000
       Long-term Assets Other 
0
0
0
0
0
9,532
0
0
0
0
0
0
0
0
0
0
00000000009,53200000
> Total Liabilities 
1,486
1,377
1,164
675
13,461
18,479
30,962
32,105
24,020
20,165
23,825
35,149
42,083
42,978
38,156
0
038,15642,97842,08335,14923,82520,16524,02032,10530,96218,47913,4616751,1641,3771,486
   > Total Current Liabilities 
443
559
544
401
5,562
11,604
18,476
20,117
13,556
14,636
18,635
21,704
34,215
41,240
37,816
0
037,81641,24034,21521,70418,63514,63613,55620,11718,47611,6045,562401544559443
       Short-term Debt 
0
0
0
88
3,247
7,647
10,080
11,026
8,514
8,770
12,061
11,780
25,897
30,432
25,472
0
025,47230,43225,89711,78012,0618,7708,51411,02610,0807,6473,24788000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
7,338
11,250
6
25,472
0
025,472611,2507,33800000000000
       Accounts payable 
329
289
244
99
790
896
3,545
2,817
2,966
2,660
2,760
3,412
4,170
3,867
2,710
0
02,7103,8674,1703,4122,7602,6602,9662,8173,54589679099244289329
       Other Current Liabilities 
114
270
300
214
529
1,133
4,851
6,275
2,077
3,206
3,490
5,994
3,415
6,650
9,220
0
09,2206,6503,4155,9943,4903,2062,0776,2754,8511,133529214300270114
   > Long-term Liabilities 
0
0
0
274
7,899
6,875
12,486
11,988
10,465
5,529
5,190
13,446
7,869
1,738
340
0
03401,7387,86913,4465,1905,52910,46511,98812,4866,8757,899274000
       Other Liabilities 
0
0
0
0
0
13,726
4,162
3,369
1,914
1
0
365
367
369
340
0
0340369367365011,9143,3694,16213,72600000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
367
369
340
0
0340369367000000000000
> Total Stockholder Equity
6,468
6,400
5,413
5,087
4,519
12,233
25,138
24,639
34,568
38,791
21,880
5,670
-2,505
11,238
19,136
0
019,13611,238-2,5055,67021,88038,79134,56824,63925,13812,2334,5195,0875,4136,4006,468
   Common Stock
15
15
15
20
40
40
81
83
46
49
50
50
50
70
76
0
0767050505049468381404020151515
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
56
190
381
621
461
526
1,886
2,658
2,957
2,979
3,066
1,724
0
01,7243,0662,9792,9572,6581,88652646162138119056000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
10,380
7,200
18,603
36,750
39,104
49,595
57,382
58,002
58,297
58,315
66,457
73,630
0
073,63066,45758,31558,29758,00257,38249,59539,10436,75018,6037,20010,380000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-15
Operating Income-15-15
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense150
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-15
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15-15
EBIT - interestExpense = -183
-183
-15
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-183-15
Earnings Before Interest and Taxes (EBITDA)-15
 
After tax Income (+$)
Income Before Tax-15
Tax Provision-0
Net Income From Continuing Ops0-15
Net Income-15
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15
Total Other Income/Expenses Net00
 

Technical Analysis of Aoxing Pharmaceutical Company Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aoxing Pharmaceutical Company Inc. The general trend of Aoxing Pharmaceutical Company Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aoxing Pharmaceutical Company Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aoxing Pharmaceutical Company Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 0.0139 > 0.0139 > 0.0134.

Tweet this
Aoxing Pharmaceutical Company Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aoxing Pharmaceutical Company Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aoxing Pharmaceutical Company Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aoxing Pharmaceutical Company Inc. The current macd is 0.00058341.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Aoxing Pharmaceutical Company Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Aoxing Pharmaceutical Company Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Aoxing Pharmaceutical Company Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Aoxing Pharmaceutical Company Inc Daily Moving Average Convergence/Divergence (MACD) ChartAoxing Pharmaceutical Company Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aoxing Pharmaceutical Company Inc. The current adx is 29.99.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aoxing Pharmaceutical Company Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Aoxing Pharmaceutical Company Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aoxing Pharmaceutical Company Inc. The current sar is 0.0066.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Aoxing Pharmaceutical Company Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aoxing Pharmaceutical Company Inc. The current rsi is 73.71. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Aoxing Pharmaceutical Company Inc Daily Relative Strength Index (RSI) ChartAoxing Pharmaceutical Company Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aoxing Pharmaceutical Company Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Aoxing Pharmaceutical Company Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Aoxing Pharmaceutical Company Inc Daily Stochastic Oscillator ChartAoxing Pharmaceutical Company Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aoxing Pharmaceutical Company Inc. The current cci is 174.40.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Aoxing Pharmaceutical Company Inc Daily Commodity Channel Index (CCI) ChartAoxing Pharmaceutical Company Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aoxing Pharmaceutical Company Inc. The current cmo is 56.36.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Aoxing Pharmaceutical Company Inc Daily Chande Momentum Oscillator (CMO) ChartAoxing Pharmaceutical Company Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aoxing Pharmaceutical Company Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Aoxing Pharmaceutical Company Inc Daily Williams %R ChartAoxing Pharmaceutical Company Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aoxing Pharmaceutical Company Inc.

Aoxing Pharmaceutical Company Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aoxing Pharmaceutical Company Inc. The current atr is 0.00122622.

Aoxing Pharmaceutical Company Inc Daily Average True Range (ATR) ChartAoxing Pharmaceutical Company Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aoxing Pharmaceutical Company Inc. The current obv is 935,866.

Aoxing Pharmaceutical Company Inc Daily On-Balance Volume (OBV) ChartAoxing Pharmaceutical Company Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aoxing Pharmaceutical Company Inc. The current mfi is 99.78.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Aoxing Pharmaceutical Company Inc Daily Money Flow Index (MFI) ChartAoxing Pharmaceutical Company Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aoxing Pharmaceutical Company Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Aoxing Pharmaceutical Company Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aoxing Pharmaceutical Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5073.707
Ma 20Greater thanMa 500.008
Ma 50Greater thanMa 1000.007
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.011
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Aoxing Pharmaceutical Company Inc with someone you think should read this too:
  • Are you bullish or bearish on Aoxing Pharmaceutical Company Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aoxing Pharmaceutical Company Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aoxing Pharmaceutical Company Inc

I send you an email if I find something interesting about Aoxing Pharmaceutical Company Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Aoxing Pharmaceutical Company Inc.

Receive notifications about Aoxing Pharmaceutical Company Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.